What You Need to Know About the J&J Vaccine Blood Clot Risk
Six people, out of over 6 million who have received the Johnson & Johnson/Janssen COVID vaccine, have developed a rare type of blood clot. As a result, the FDA and CDC have announced a pause in the use of this vaccine. The pause is likely to last just a few days.